1-6 of 6
Meghali Goswami, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia

Katherine E Lindblad, Julie Thompson, RN, Gege Gui, MS, Janet Valdez, Tatyana Worthy, Hanna Tekleab, Tom Hughes, Pharm.D., Meghali Goswami, BS, Karolyn Oetjen, MD, Dong-Yun Kim, PhD, Laura Dillon, PhD, Christin DeStefano, MD, Catherine E. Lai, MD, Christopher S. Hourigan, DPhil FACP FRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 1437.
https://doi.org/10.1182/blood-2018-99-115097
Published: 2018
Journal Articles

Blood Transcriptional Profiling in Patients with Leukemic Cutaneous T-Cell Lymphoma on Extracorporeal Photopheresis Reveals the Integrin Signaling As the Top Pathway Associated with Clinical Response

Zuolin Ying, MD PhD, Madeleine Duvic, MD, Lisa Shiue, PhD, Timothy Langridge, BS, Meghali Goswami, BS, Xiao Ni, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3981.
https://doi.org/10.1182/blood.V126.23.3981.3981
Published: 2015
Journal Articles

A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Meghali Goswami, BS, Katherine S. McGowan, Kit Lu, MD, Natasha A Jain, MD, Julián Candia, PhD, Nancy F. Hensel, Jingrong Tang, MDPhD, Katherine R. Calvo, MD, PhD, Minoo Battiwalla, MDMS, Austin John Barrett, MDFRCP,FRCPath, Christopher S. Hourigan, MDPhD
Journal: Blood
Blood (2014) 124 (21): 667.
https://doi.org/10.1182/blood.V124.21.667.667
Published: 2014
Journal Articles

A Novel Multi-Gene Expression Array Allows Highly Sensitive Detection Of Minimal Residual Disease and Predicts Relapse Outcomes In Acute Myeloid Leukemia

Meghali Goswami, BS, Katherine S. McGowan, Kit Lu, MD, Sandhya R. Panch, MD, MPH, Nancy F. Hensel, Minoo Battiwalla, MD, MS, A. John Barrett, MD, Christopher S. Hourigan, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3318.
https://doi.org/10.1182/blood.V122.21.3318.3318
Published: 2013
Journal Articles

Correlation of Target Molecule Expression and Overall Response in Refractory Cutaneous T-Cell Lymphoma Patients Dosed with Mogamulizumab (KW-0761), a Monoclonal Antibody Directed Against CC Chemokine Receptor Type 4 (CCR4)

Madeleine Duvic, MD, Lauren Pinter-Brown, Francine Foss, MD, Lubomir Sokol, MD, PhD, Jeffrey Jorgensen, MD, PhD, Xiao Ni, MD, PhD, Pramoda Challagundla, MS, Meghali Goswami, BS, Karen Dwyer, Nehal Mohamed, PhD, Youn H Kim, MD
Journal: Blood
Blood (2012) 120 (21): 3697.
https://doi.org/10.1182/blood.V120.21.3697.3697
Published: 2012
Journal Articles

Effects of Anti-CCR4 Antibody (KW-0761) on Regulatory T Cells and Natural Killer Cells in Patients with Cutaneous T-Cell Lymphoma

Xiao Ni, MD, PhD, Jeffrey L. Jorgensen, MD, PhD, Meghali Goswami, BS, Pramoda Challagundla, MS, William K Decker, PhD, Youn H. Kim, MD, Madeleine Duvic, MD
Journal: Blood
Blood (2011) 118 (21): 444.
https://doi.org/10.1182/blood.V118.21.444.444
Published: 2011